Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Orally bioavailable dabigatran prodrugs for the treatment of diseases

Orally bioavailable dabigatran prodrugs for the treatment of diseases

US Patent 8853245 · Granted Oct 7, 2014

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Pyrido-phenanthroline derivatives, production and use thereof as medicaments2021
Compounds for the treatment of influenza2017
Compounds for the treatment of influenza2017
Compounds for the treatment of influenza2017
Antibacterial and antifungal biphenylyl compounds2017
Orally bioavailable pentamidine prodrugs for the treatment of diseases2017
Orally bioavailable pentamidine prodrugs for the treatment of diseases2017
Orally bioavailable pentamidine prodrugs for the treatment of diseases2017
Compounds for inhibition of cancer cell proliferation2016
N-ω-hydroxy-L-arginine derivatives for the treatment of diseases2016
N-ω-hydroxy-L-arginine derivatives for the treatment of diseases2016
Method for producing prodrug from amidoxime and N-hydroxyguanidine carboxylic ac2016